|
APM
|
Aptorum Group Limited
|
US
|
NASDAQ
|
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APTCF
|
Advanced Proteome Therapeutics Corporation
|
US
|
US
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
APTX
|
Aptinyx Inc.
|
US
|
NASDAQ
|
|
APVO
|
Aptevo Therapeutics Inc.
|
US
|
NASDAQ
|
|
AQB
|
AquaBounty Technologies, Inc.
|
US
|
NASDAQ
|
|
AQST
|
Aquestive Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AQSZF
|
Aequus Pharmaceuticals Inc
|
US
|
OTC
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
US
|
NASDAQ
|
|
ARDS
|
Aridis Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ARDX
|
Ardelyx, Inc.
|
US
|
NASDAQ
|
|
ARGX
|
Argen-X
|
BE
|
BR
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
ARMP
|
Armata Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
ARNI
|
Arno Therapeutics
|
US
|
US
|
|
AROC
|
AroCell AB
|
SE
|
ST
|
|
ARTL
|
Artelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
ARTLW
|
Artelo Biosciences Inc
|
US
|
US
|